253M people worldwide are visually impaired of which 80% can be prevented or cured. Novartis is reimagining the treatment and prevention of visual impairment and blindness. We aim to develop life-changing pharmaceuticals and transformative technologies for diseases and conditions from front to back of the eye. NIBR's Ophthalmology group is working on treatments for the leading causes of blindness as well as cell and gene therapies for rare diseases, a new frontier in medicine that can enable us to transform eye care for patient. The Translational Medicine (TM ) Discovery & Profiling (TMDP) group is a team of physicians and clinical researchers who drive that innovation science from discovery to the patient through the selection, profiling and effective development of medi
This job listing is no longer active.
Check the left side of the screen for similar opportunities.